For NEW Patient Copay Assistance information, please click on this link

Get your patients started on AJOVY. Begin here

Frequently asked questions

Efficacy results for AJOVY

With AJOVY, patients may experience significantly more migraine-free days vs placebo, and lasting protection against migraine1*

Learn more about efficacy results for AJOVY

*“Lasting protection” defined as reduction in monthly average migraine or headache days measured over a 12-week period following a monthly 225 mg SC dose or quarterly 675 (225 mg x 3) SC dose.1

SC: subcutaneous.